Nihon Kohden Cuts FY2025 Sales and Profit Outlook on Weaker Domestic Demand

Nihon Kohden Corporation ( (JP:6849) ) has shared an announcement.

Nihon Kohden revised its consolidated financial forecast for the fiscal year ending March 31, 2026, cutting expected net sales to ¥235 billion from ¥240 billion and operating income to ¥20 billion from ¥24 billion, while keeping income attributable to owners of parent unchanged at ¥12.5 billion. The downgrade is driven mainly by weaker-than-expected domestic demand, as universities and public hospitals postponed or restrained equipment purchases amid deteriorating business sentiment, and by softer AED sales due to distributor inventory adjustments, even as the company continues to push consumables, services, and medical IT systems. Overseas sales guidance in yen terms is unchanged but will be influenced by a weaker yen and cautious decision-making on patient monitor purchases in North America, as well as regulatory compliance requirements in Asia and other regions; ordinary income is now forecast at ¥22 billion, supported by foreign exchange gains, and the company is focusing on restraining SG&A growth and reforming its profit structure to mitigate the impact of lower sales and margins.

The most recent analyst rating on (JP:6849) stock is a Buy with a Yen2015.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

More about Nihon Kohden Corporation

Nihon Kohden Corporation is a Japan-based medical device manufacturer listed on the Tokyo Stock Exchange Prime Market, specializing in patient monitoring systems, medical electronics, defibrillators including automated external defibrillators (AEDs), and related consumables and services for hospitals and healthcare institutions in Japan and overseas.

Average Trading Volume: 618,093

Technical Sentiment Signal: Buy

Current Market Cap: Yen285.9B

For an in-depth examination of 6849 stock, go to TipRanks’ Overview page.